2) Decision Resources, Inc. “Vancomycin Continues to Dominate MRSA Treatment with up to 76 Percent of Surveyed Infectious Disease Specialists Indicating That They Use the Agent as First-Line Treatment for a Range of MRSA Infections.” May 23, 2011.
3) “Drug-resistant Streptococcus pneumoniae Disease.” National Center for Immunization & Respiratory Diseases: Division of Bacterial Diseases, 2010. www.cdc.gov/ncidod/dbmd/diseaseinfo/drugresisstreppneum_t.htm
6) “Diagnosis and Management of Acute Otitis Media: Clinical Practice Guidelines.” Pediatrics Vol. 113 No. 5 May 2004, pp. 1451-1465.
7) Affiliated Community Medical Centers (ACMC). “Acute Otitis Media.” (2009) www.acmc.com/careimprovement/pedia_acuteOtitis.cfm
8) The physicians’ denigrating attitude toward naturopathic medicine is summed up by Dr. Paul G. Donohue, M.D. in “How You Can Control Arthritis.” To Your Good Health, Summer 1992. “When a real cure is devised for a disease, the old ‘grandma remedies’ rapidly die. But until then, they flourish.” In other words, ignore any consideration of alternative theories, no matter what evidence of success exists.
9) A small representative sample of media reporting on this topic includes: “Bacteria Wages War on Antibiotics.” South Bay Daily Breeze, November 5, 2001, pg B3; Hull, Dr. Janet. “Over-Prescribed Antibiotics.” 8/2007 online newsletter; “Antibiotics Still Over-prescribed.” Connexion, France’s English language newspaper, January 25, 2011.; Writing, A. “Treatment for Extended-spectrum beta-lactamases (ESBL)” at www.ehow.com
10) Personal communication with Dr. Tsuyoshi Okada, July 2009.
11) Kuyumjian, AG, PharmD, Levine, JF, MD, “A Prospective Study of Antibiotic Cost Containment in a University Teaching Hospital over a 13-Year Period.” P&T. Vol 27 No 11, November 2002.
12) Pesach Shvartzman, chairman.“ Careful prescribing is beneficial.” BMJ 309: 1011 (15 October 1994)
13) Centor RM, Meier FA, Dalton HP. “Throat cultures and rapid tests for diagnosis of group A streptococcal pharyngitis.” Ann Intern Med. 1986 Dec;105(6):892-9. Online at www.ncbi.nlm.nih.gov/pubmed/3535604
14) Sefton AM. “Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium.” Drugs. 2002;62(4):557-66. Online at http://www.ncbi.nlm.nih.gov/pubmed/11893225
15) The Sanford Guide to Antimicrobial Therapy is published annually as an excellent cross-reference to see comparison tables of medications versus particular microbes and diseases/conditions. See www.sanfordguide.com
16) Clark (1997) p. 34.
18) McKenna, M. presents several articles on FDA and farm antibiotics online at http://www.wired.com/wiredscience/superbug (2011)
19) American Society for Microbiology. "Newly discovered reservoir of antibiotic resistance genes." ScienceDaily, 20 Oct. 2011. Online at http://www.sciencedaily.com/releases/2011/10/111020164020.htm
20) “Antimicrobial Drugs Approved for Use in Food-Producing Animals: 2009 Sales and Distribution Data Reported by Drug Class.” http://www.livablefutureblog.com/2010/12/new-fda-numbers-reveal-food-animals-consume-lion%E2%80%99s-share-of-antibiotics
21) Unattributed article. “Agricultural Antibiotic Use Contributes To 'Super-Bugs' In Humans.” ScienceDaily (July 5, 2005)
26) http://www.ra-infection-connection.com/ongoing.htm specific article
27) Marion Nestle. “Food Politics” Online at http://www.foodpolitics.com/2010/07/two-gao-reports-on-food-safety-at-the-fda/
28) Expert Affidavit to the FDA on Safety of Irradiated Food By William W. Au, Ph.D. October 28, 2001
29) Bulletin of the World Health Organization, 41:873-904, 1969. Cosponsored by the US Atomic Energy Commission and the Food and Drug Administration.
30) Mutation Research, 80:333-345, 1981.
31) Morehouse, KM and Komolprasert V. “Irradiation of Food and Packaging: An Overview.” ACS Symposium Series 875, Irradiation of Food and Packaging. Chapter 1, Pages 1-11. (2004) at www.fda.gov
32) Caulfield CD, Cassidy JP, Kelly JP. “Effects of Gamma Irradiation and Pasteurization on the Nutritive Composition of Commercially Available Animal Diets.” J Am Assoc Lab Anim Sci. 2008 November; 47(6): 61–66. www.ncbi.nlm.nih.gov/pmc/articles/PMC2687132/
33) Grolichová M, Dvofiák P, Musilová H. “Employing Ionizing Radiation to Enhance Food. Safety – a Review.” Acta Vet. Brno 2004, 73: 143-149. Online at actavet.vfu.cz/pdf/200473010143.pdf
34) Agriculture Research Service. “Background: Food Irradiation.” December 10, 1997.
38) Lee HS, Sobsey MD. “Survival of prototype strains of somatic coliphage families in environmental waters and when exposed to UV low-pressure monochromatic radiation or heat.” Water Res. 2011 Jun;45(12):3723-34. Online at http://www.ncbi.nlm.nih.gov/pubmed/21600626
39) Osterholm, M.T. and Potter, M.E. “Irradiation Pasteurization of Solid Foods: Taking Food Safety to the Next Level.” Emerging Infectious Disease, Vol. 3(4), 1997.
41) Use the search engine at www.mercola.com or use Google with key words “irradiation” and “beef.”
42) Moss, Michael, “Safety of Beef Processing Method is Questioned.” New York Times, December 30, 2009. Online at http://www.nytimes.com/2009/12/31/us/31meat.html?_r=4
43) J. Anim. Sci. 2000. 78:2849-2855.
44) Dr. Mercola’s proven “Nutrition Plan for Optimal Health” can be found at www.mercola.com/nutritionplan/index.htm. Comprehensive dietary guidelines as well as lifestyle modifications are presented which, if diligently followed, will result in improved health and well-being. A recipe book is also available at this website.
46) Broxmeyer L. “Is Mad Cow Disease Caused By a Bacteria?” Medical Hypotheses (2004) 63, 731–739. Online at http://drbroxmeyer.netfirms.com/MadCow.htm
47) “What You Need to Know about Mercury in Fish and Shellfish.” EPA-823-R-04-005. March 2004.
49) Historical timeline at http://tch.ucsd.edu/chem259/259_lecture_02_2008.pdf
50) Garrett ( 1995) p. 36.
51) Ibid., pp. 428-30.
55) Bureau of Epidemiology. “Rheumatic Fever in Utah, 1998: When a sore throat isn’t just a sore throat.” Dept of Health Newsletter, 1998.
56) Eustice, C. “Polyarthritis is one of the major criteria associated with rheumatic fever.” (2006) http://arthritis.about.com/od/othercond/a/ rheumaticfever.htm
57) “Horrible.” Unattributed feature article. The Economist, May 28, 1994, p. 52.
59) Garrett ( 1995) pp. 414-415 and pp. 670-4.
60) Monmaney, Terrence. “Antibiotic-Resistant Bugs on the Rise, Federal Study Finds.” Los Angeles Times. Vol. 115, No. 30, p. 2. 8/24/1995.
62) Via the Internet at www.cdc.gov from the CDC Division of Bacterial and Mycotic Diseases. Newly identified bacterial pathogens with unusual patterns of drug resistance constitute the focus of this subagency of the CDC.
64) O’Brien KL, Wolfson LJ, et al. “Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.” Lancet 2009; 374: 893–902. Online at www.ncbi.nlm.nih.gov/pubmed/19748398
65) Garrett (1995) pp. 226-233.
66) Study results summarized by Lori Oliwenstein. “Understanding T-Cells,” Arthritis Today, January/February 1996. The scientists, whose experiment was first published in Immunity, speculated that RA patients most likely have another gene to account for the T-cell difference.
67) Ewald, Paul W. “The Evolution of Virulence.” Scientific American, April 1993.
68) Invading pathogenic microbes cause severe and rapid depletion of vitamin C, leading to painful symptoms. See our website article
69) Chia-Hung Chiang, et al. “Association Between Mycoplasma Pneumonia and Increased Risk of Ischemic Stroke.” Online at http://stroke.ahajournals.org/content/early/2011/07/28/STROKEAHA.110.608075
70) Transposons were discovered and named by Dr. Barbara McClintock, for which she received the 1990 Nobel Prize in Medicine.
71) Garrett (1995) p. 432.
72) Remarks by bacteriologist Alexander Tomasz, “Disease Causing Bacteria Resistant to Antibiotics,” at the annual meeting of the American Association for the Advancement of Science, San Francisco, February 19, 1994.
73) Some estimates now put this figure at nearer 40 million.
74) Streptococcus pneumoniae also has so many different strains that one exposure does not immunize against the dozens of others.
75) Taubenberger JK, Reid AH, et al. “Characterization of the 1918 influenza virus polymerase genes.” Nature. 2005 Oct 6;437(7060):889-93.
76) Garrett (1995) p. 160.
77) Broxmeyer L. “SARS: Just another viral acronym?” (2003) http://drbroxmeyer.netfirms.com/sars.pdf
78) All direct quotes in this chapter are found in Dr. Baseman, JB, Dr. Tully, JG, “Mycoplasmas: Sophisticated, Reemerging and Burdened by Their Notoriety.” CDC's Emerg Infect Dis, 1997; 3:1.
79) Appendix “Antibiotics: Efficacy Against Susceptible Pathogens.” Physician’s Drug Handbook (2007)
81) Overview at www.ra-infection-connection.com/MarshallProtocol.htm
82) Garrett (1995) pp. 582-6.
83) Stein GE and Craig WA. “Tigecycline: A Critical Analysis.” Clin Infect Dis. (2006) 43 (4): 518-524. Online at http://cid.oxfordjournals.org/content/43/4/518.full
84) The mortality warning accompanies the original drug cautions, but in 2010, the FDA repeated the warning in a special safety announcement. www.fda.gov/Drugs/DrugSafety/ucm224370.htm
85) Lewis, Kim. “Persister Cells.” Annu. Rev. Microbiol. 2010, 64:357-372. Online at www.northeastern.edu/adc/publications.php
86) Banerjee B, Petersen K. “Psychosis following mycoplasma pneumonia.” Mil Med. 2009 Sep;174(9):1001-4.
87) Krause D, Matz J, et al. “The association of infectious agents and schizophrenia.” World J Biol Psychiatry. 2010 Aug;11(5):739-43.
88) Müller N, Riedel M, et al. “Mycoplasma pneumoniae infection and Tourette's syndrome.”` Psychiatry Res. 2004 Dec 15;129(2):119-25.
89) A fine overview entitled “Autoimmune Illnesses and Degenerative Diseases” by Prof. Garth Nicolson can be found at www.immed.org/illness/ autoimmune_illness_research.html.
90) Nicolson GL, Nasralla MY, Haier J, Erwin R, Nicolson NL, and Ngwenya R. “Mycoplasmal Infections in Chronic Illnesses: Fibromyalgia and Chronic Fatigue Syndromes, Gulf War Illness, HIV-AIDS and Rheumatoid Arthritis.” Medical Sentinel 1999; 4:172-176.
91) References at immed.org: J Amer Nutraceut Assoc 2003; 6(3):22-28 Pathol Oncol Res 2005; 11:139-144 J Chronic Fatigue Synd 2006; 13(4):57-68 J Amer Nutraceut Assoc 2010; 13(1):11-15.
92) Nicolson, GL. “Systemic Intracellular Bacterial Infections (Mycoplasma, Chlamydia, Borrelia species) in Neurodegenerative (Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Alzheimer's) and Behavioral (Autistic Spectrum Disorders) Diseases” Online at www.townsendletter.com/April2008/systemicintracel_notes0408.htm
93) refer to our website (www.RA-Infection-Connection.com) and peruse many articles on vitamin C
94) Linker III, Joe B. and Williams Jr., Ralph C. “Tests for Detection of Rheumatoid Factors,” in Rose (1986) pp. 759-761.
95) Repeated stimulus of the immune system with TB test materials can significantly extend the life of melanoma patients. This treatment was given to a family friend whose life was saved as a result.
96) Tully, Dr. J. G. “Reflections: Some Personal Impressions of Early Life and Forty Years of Mycoplasmology.” Prepared for the Archives of the International Organization for Mycoplasmology upon his retirement from the National Institutes of Health in 2001.
101) Cassinotti P, et al. “Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin.” J Med Virol. 1998 Nov;56(3):199-204. Online at http://www.ncbi.nlm.nih.gov/pubmed/9783685
102) Written testimony of Dr. Garth L. Nicolson to the Congressional Committee on Government Reform (Subcommittee on National Security, Veterans’ Affairs and International Relations), January 24, 2002.
103) National Academies Report: “Gulf War Service Linked to Post-Traumatic Stress Disorder, Multisymptom Illness, Other Health Problems, But Causes Are Unclear.” April, 2010. Online at http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12835
104) Hilborne and Golomb (2001) pg 9.
105) Steele L, Sastre A, et al. “Complex Factors in the Etiology of Gulf War Illness: Wartime Exposures and Risk Factors in Veteran Subgroups.” Environmental Health Perspectives, 2011. Online at http://www.sciencedaily.com/releases/2011/09/110919074247.htm
106) Also Nicolson GL, Nasralla MY, et al. “High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with Amyotropic Lateral Sclerosis (ALS).” Journal of Clinical Neuroscience 2002;9;525-9)
108) Gherardi RK. “Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome.” Rev Neurol (Paris). 2003 February 159(2):162-4.
109) Dr. Alan Cantell, Jr., M.D. Are Vaccines Causing More Disease Than They Are Curing?” http://www.gulfwarvets.com/vexing.htm (1999)
112) Blaylock RL.” Chronic microglial activation and excitotoxicity secondary to excessive immune stimulation: Possible factors in Gulf War Syndrome and Autism.” J Amer Phys Surg 2004; 9: 46-51. Online at http://www.nationalautismassociation.org/pdf/blaylockvaccinepaper.pdf
114) At this writing, there are actually 19 studies referred to by “experts” as providing “overwhelming evidence.”
115) “International Medical Council on Vaccination refutes vaccine propaganda with myth-busting report.” Free downloadable 2011 report at www.naturalnews.com/031173_vaccines_science.html
116) For the CDC’s point of view, see www.cdc.gov/vaccinesafety/Vaccines/multiplevaccines.html (2011)
117) See these websites for more information on ASD: www.autism-society.org , www.autismspeaks.org/site-wide/cure-autism-now , www.delimmune.com/research/improvements-in-gastrointestinal-symptoms-among-children-with-autism/ , www.ninds.nih.gov/disorders/autism/detail_autism.htm , http://blog.ehealthmedicare.com/media-center/infographics/?pid=1 , www.helpguide.org/mental/autism_help.htm , http://safesoundfamily.com/p/autism-safety/ , and www.immed.org for ongoing research.
119) “Health Consequences of Service During the Persian Gulf War: Recommendations for Research and Information Systems.” Testimony given by Dr. Garth Nicolson to the Congressional Committee to Review the Health Consequences of Service During the Persian Gulf War, Washington, DC, 1996.
120) Thomas JL, Wilk JE, et al. “Prevalence of Mental Health Problems and Functional Impairment Among Active Component and National Guard Soldiers 3 and 12 Months Following Combat in Iraq.” Arch Gen Psychiatry. 2010;67(6):614-623. Online at http://archpsyc.ama-assn.org/cgi/content/full/67/6/614
121) Interview comments to Dr. Roger G. Mazlen, host of the Chronic Fatigue Syndrome Radio Show, January 4, 1998.
122) Dr. Nicolson’s daughter served in the Gulf as a helicopter pilot. Her complaints of unusual joint pain and fatigue piqued Dr. Nicolson’s interest in the cause of these symptoms, and led him and his wife Nancy (also a health professional) to the in-depth investigation of GWI, research into pathogenic Mycoplasma strains, and eventually the establishment of a world class infectious organism testing facility in California.
123) Nicolson GL, Nasralla MY, Berns P, Haier, J. “Chronic Mycoplasmal Infections in Autism Patients.” Institute for Molecular Medicine, Huntington Beach, CA. (2000).
126) Nasralla M.; Haier, J. and Nicolson, G.L. “Multiple Mycoplasmal Infections Detected in Blood of Chronic Fatigue and Fibromyalgia Syndrome Patients.” Eur J Clin Microbiol Infect Dis 18:359-365, 1999.
127) Vojdani A, Franco AR. “Multiplex PCR for the Detection of Mycoplasma fermentans, M. hominism, and M. penetrans in Patients with Chronic Fatigue Syndrome, Fibromyalgia, Rheumatoid Arthritis, and Gulf War Syndrome.” Journal of Chronic Fatigue Syndrome Vol. 5, No. 3/4, 1999, pp. 187-197. Online at www.thearthritiscenter.com/pub_multiplex.htm
128) Cretney E, McQualter JL, et al. “TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.” Immunology and Cell Biology (2005) 83, 511–519. www.nature.com/icb/journal/v83/n5/full/icb200569a.html
129) Yamamoto, Y. “PCR in Diagnosis of Infection: Detection of Bacteria in Cerebrospinal Fluids.” Clin Diagn Lab Immunol. 2002 May; 9(3): 508–514
133) Stratton, C; Mitchell, W; Sriram, S. “Does Chlamydia pneumoniae Play a Role in the Pathogenesis of Multiple Sclerosis? J Med Microbiol 2000 Jan;49(1):1-3.
134) Sriram, S; Mitchell, W. and Stratton, C. “Multiple Sclerosis Associated with Chlamydia pneumoniae Infection of the CNS.” Neurology 1998 Feb;50(2):571-2
135) David Wheldon MB FRCPath. “Empirical antibacterial treatment of infection with Chlamydophila pneumoniae in Multiple Sclerosis.” (2009).
136) Dr. Lindner’s research is found on the ThisIsMS support group site: www.thisisms.com/forum/antibiotics-f28/topic572.html (2004)
137) Nicolson, G.L. and Nicolson, N.L. “Autoimmune Neurological and Rheumatic Diseases: Role of Chronic Infections in Morbidity and Progression.” Proceedings 13th International Symposium on Integrative Medicine 2001; 13:104-112.
138) Ablashi DV, Lapps W, et al. “Human Herpes Virus-6 (HHV-6) Infection In Multiple Sclerosis.” Mult Scler 1998 Dec;4(6):490-6.
139) Many research references at www.hhv-6foundation.org/associated-conditions/hhv-6-and-multiple-sclerosis
140) See www.cdc.gov/ncidod/eid/vol5no3/campadelli.htm for collected CDC studies online (1999)
142) For more information, contact the National Multiple Sclerosis Society, NY, NY. www.nationalmssociety.org/index.aspx
143) Naubauer, RA. “Protocol for the Treatment of Multiple Sclerosis with Hyperbaric Oxygen.” J. Hyperbar Med 1990; 5:53-54.
144) Vitamin C is also effective against and Human papillomavirus (HPV). See www.doctoryourself.com/herpes.html (2007)
146) Reported Tuberculosis in the United States, 2009. Executive Commentary.” Online at www.cdc.gov.
148) Bloom BR. Public Health in Transition. Sci Am. 2005; 293(3):92-9.
150) "ALS (Amyotrophic Lateral Sclerosis) Fact Sheet," NINDS. February 2010. NIH Publication No. 10-916. Online at www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/detail_ALS.htm
151) Statistics and research available at www.immed.org.
152) Nicolson, GL. Systemic Intracellular Bacterial Infections (Mycoplasma, Chlamydia, Borrelia species) in Neurodegenerative (Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Alzheimer's) and Behavioral (Autistic Spectrum Disorders) Diseases.” In the Townsend Letter, April 2008.
153) Berger MM, Kopp N, et al. “Detection and Cellular Localization of Enterovirus RNA Sequences in Spinal Cord of Patients with ALS.” Neurology 2000; 54:20-25. Also Nicolson GL, Nasralla M, and Nicolson N. “The Pathogenesis and Treatment of Mycoplasmal Infections.” Antimicrob Infect Dis Newsl 1999; 17:81-88.
154) Johnson R, Schell R, Waisbren B. “Borrelia burgdorferi Antibodies and Amyotrophic Lateral Sclerosis.” Lancet, August 8, 1987. In this article, reference is made to Drs. Stanek, Pachner Reik, Steere and Dattwyler, who actively downplayed Lyme at the time.
155) Halperin, JJ, MD, Kaplan, GP, MD, et al. “Immunologic Reactivity Against Borrelia burgdorferi in Patient with Motor Neuron Disease.” Archives of Neurology, Vol 47, May 1990.
156) Hansel Y, Ackerl M, Stanek G. “ALS-like sequelae in chronic neuroborreliosis.” Wien Med Wochenschr, 1995; 145(7-8):186-8.
157) Binfaré, RW, et al. “Ascorbic acid administration produces an antidepressant-like effect: Evidence for the involvement of monoaminergic neurotransmission.” Progress in Neuro-Psychopharmacology & Biological Psychiatry (ISSN 0278-5846) Impact factor: 2.823, v. 33, p. 530-540, 2009.
158) MMWR Surveill Summ. 2009 Dec 18;58(10):1-20.[45 collaborators]. “Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006.” Online at www.cdc.gov/mmwr/preview/mmwrhtml/ss5810a1.htm
159) See a free online video of an Autism Research Institute 2011 presentation “Autism as a Multisystem, Whole-Body Disorder” at http://www.ariconference.com/.
164) Rossignal DA, Rossignol LW. “Hyperbaric oxygen therapy may improve symptoms in autistic children.” Medical Hypotheses (2006) http://sirricenter.com/pdfs/HBOT_autism.pdf
165) Rossignal DA, Rossignol LW, et al. “Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.” BMC Pediatrics 2009, 9:21. Online at www.biomedcentral.com/1471-2431/9/21
166) Nicolson GL, Gan R, Nicolson NL, Haier J. “Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpes virus-6 coinfections in the blood of patients with autistic spectrum disorders.” J Neurosci Res. 2007 Apr;85(5):1143-8.
167) Besides Dr. Nicolson’s considerable research at www.immed.org, also see www.ageofautism.com/2011/04/the-potential-importance-of-the-xmrv-retrovirus-to-autism.html
168) www.whale.to/y/autism_vitA.html (1999)
169) Cannell JJ. “On the aetiology of autism.” Acta Pædiatrica 2010 99, pp. 1128–1130. Also Levenson CW, Figueiroa SM. “Gestational vitamin D deficiency: long-term effects on the brain.” Nutr Rev 2008; 66:726–9.
171) Annweiler C, Schott AM, et al. “Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study.” Neurology. 2010 Jan 5;74(1):27-32.
172) Knekt P, Kilkkinen A, et al. “Serum Vitamin D and the Risk of Parkinson Disease.” Arch Neurol. 2010;67(7):808-811
173) http://autism-nutrition.com/vitamin-b12-autism (2011)
175) Parracho M, et al. “Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children.” J. Med. Microbiol. 54, 987-991 (2005)
176) http://pptu.lefora.com/2010/12/01/pptu-autism-asd/. Study done by Metametrix.
177) Valicenti-McDermott M, et al. “Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease.” J. Dev. Behav. Pediatr. 27, S128-36 (2006)
178) Frigsman A, et al. “Clinical Presentation and Histologic Findings at Ileocolonoscopy in Children with Autistic Spectrum Disorder and Chronic Gastrointestinal Symptoms.” Autism Insights 2010:2 1-11. Online at www.la-press.com/clinical-presentation-and-histologic-findings-at-ileocolonoscopy-in-ch-article-a1816
179) Diaz Heijtz R, et al. “Normal gut microbiota modulates brain development and behavior.” Proc. Natl. Acad. Sci. (2011)
180) Unattributed, from the Behavioural Neurothrapy Clinic, Doncaster, Victoria, Australia. “Cellular malnutrition and Intestinal Dysbiosis in Autism.” Online at www.adhd.com.au/Intestinal_Dysbiosis.htm (2010)
181) Fasano, Dr. Alessio. Presentation at April 2010 DAN! Conference in Baltimore, MD. “Intestine, Leaky Gut, and Autism: A Serendipitous Association of a Planned Design?”
182) Vojdani A, “A Gut Feeling for Immune Dysregulation & Neuroinflammation in Autism” (2008). Online at http://www.immunoscienceslab.com/Articles/A%20Gut%20Feeling%20US.pdf
185) See collected research at http://www.ra-infection-connection.com/KalokerinosAA-VaccinesRefs.htm
187) Graham M, Edwards MJ. “Teratogen Update: Gestational Effects of Maternal Hyperthermia Due to Febrile Illnesses and Resultant Patterns of Defects in Humans.” Teratology 58: 209–21. 1998.
188) Conversation with Dr. Hawkins Kirk, February, 2011.
189) www.inchem.org/documents/ehc/ehc/ehc22.htm (1982)
190) Hynynen K, et al. “Potential adverse effects of high-intensity focused ultrasound exposure on blood vessels in vivo.” Online at www.sciencedirect.com/science/article/pii/0301562995020446
193) Rados, Carol. 2004. FDA Cautions Against Ultrasound "Keepsake" Images. FDA Consumer Magazine. www.fda.gov/fdac/features/2004/104_images.html.
194) Barnard, J, et al. "Autism in schools: Crisis or challenge?" The National Autistic Society. Full report online at http://www.autism.org.uk/~/media/nas/documents/about-autism/autism-library/magazines-articles-and-reports/reports/our-reports/autism%20in%20schools%20%20crisis%20or%20challenge%20full%20report.ashx
195) John Stone. “UK Government Farce Over New Adult Autism Study.” http://www.ageofautism.com/2009/09/uk-government-farce-over-new-adult-autism-study-.html. Coverups appear to be worldwide. See collected research at http://www.ra-infection-connection.com/KalokerinosAA-VaccinesRefs.htm
198) Kevin Deane, MD. “Pneumococcal Vaccination in Patients With Rheumatic Diseases.” (2011) www.medscape.com/viewarticle/738426
200) Details at www.ra-infection-connection.com/OilNutrnRevln.htm
203) Longbottom, D. “Chlamydial vaccine development.” J Med Microbiol July 2003 vol. 52 no. 7 537-540; Levine MM, Kotloff KL, et al. “Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.” Nat Rev Microbiol. 2007 Jul;5(7):540-53; Atkins, HS, Morton, M, et al. “Recombinant Salmonella vaccines for biodefence.” Vaccine Volume 24, Issue 15, April 2006, pp. 2710-17; Prucca CG, Slavin I, et al. “Antigenic variation in Giardia lamblia is regulated by RNA interference.” Nature 456, 750-754 (11 Dec 2008) and Pechine S, Janoir C, et al. “Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of C. difficile.” Vaccine. May 2007.
205) Blaylock RL, M.D..” The danger of excessive vaccination during brain development: the case for a link to Autism Spectrum Disorders (ASD).” This 2008 article and all Dr. Blaylock’s published papers and articles can be found on his website, www.russellblaylockmd.com.
206) Prandota J. "Urinary Tract Diseases Revealed after DTP Vaccination in Infants and Young Children." American Journal of Therapeutics. 2004; 11(5):344-353.
207) Pukhalsky AL, et al. “Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.” Mediators Inflamm. 2003 August; 12(4): 203–207.
209) Alderslade R., et al. “Report of the National Childhood Encephalopathy Study.” Report by the Committee on the Safety of Medicines and the Joint Committee on Vaccination and Immunisation 1981. Whooping cough. London: HMSO, 1981:79-169.
210) Bernsen R, M.D., et al. “Reported pertussis infection and risk of atopy in 8- to 12-yr-old vaccinated and nonvaccinated children.” Pediatr Allergy Immunol. Feb 2008;19;46-52.
211) www.mpwhi.com/vaccine_information.htm offers an eclectic mix of credible and unsupported advocacy articles. This URL is intended for information only, to illustrate the heated controversy surrounding vaccines. Another collection of more than 1,000 studies on vaccination injuries and failures (2002) can be found at www.webalice.it/mymmouth/Doc/Vaccini/10000studisuidannidavaccino.pdf. The authors of this book do not endorse all material presented.
215) Presentation “Controversies in Vaccinations” at the 2011 IFM International Symposium in Bellevue, WA.